A Novel MR Imaging Sequence of 3D-ZOOMit Real Inversion-Recovery Imaging Improves Endolymphatic Hydrops Detection in Patients with Ménière Disease

References

1. 1.↵
   Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease: American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–85 doi:10.1016/S0194-5998(95)70102-8 pmid:7675476

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Shephard NT

   . Differentiation of Ménière’s disease and migraine-associated dizziness: a review. J Am Acad Audiol 200617:69–80 doi:10.3766/jaaa.17.1.7 pmid:16640061

   CrossRefPubMed
3. 3.↵
   1. Lopez-Escamez JA,
   2. Carey J,
   3. Chung WH, et al

   ; Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), Korean Balance Society. Diagnostic criteria for Meniere’s disease. J Vestib Res 2015;25:1–7 doi:10.3233/VES-150549 pmid:25882471

   Abstract/FREE Full Text
4. 4.↵
   1. Iwasaki S,
   2. Shojaku H,
   3. Murofushi T, et al

   ; Committee for Clinical Practice Guidelines of Japan Society for Equilibrium Research. Diagnostic and therapeutic strategies for Meniere’s disease of the Japan Society for Equilibrium Research. Auris Nasus Larynx 2021;48:15–22 doi:10.1016/j.anl.2020.10.009 pmid:33131962

   CrossRefPubMed
5. 5.↵
   1. Merchant SA,
   2. Adams JC,
   3. Nadol JB Jr.

   Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74–81 doi:10.1097/00129492-200501000-00013 pmid:15699723

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Rauch SD,
   2. Merchant SN,
   3. Thedinger BA

   . Meniere's syndrome and endolymphatic hydrops: double-blind temporal bone study. Ann Otol Rhinol Laryngol 1989;98:873–83 doi:10.1177/000348948909801108 pmid:2817679

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Foster CA,
   2. Breeze RE

   . Endolymphatic hydrops in Ménière’s disease: cause, consequence, or epiphenomenon? Otol Neurotol 2013;34:1210–14 doi:10.1097/MAO.0b013e31829e83df pmid:23921917

   CrossRefPubMed
8. 8.↵
   1. Naganawa S,
   2. Satake H,
   3. Kawamura M, et al

   . Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence: 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol 2008;18:920–24 doi:10.1007/s00330-008-0854-8 pmid:18324405

   CrossRefPubMed
9. 9.↵
   1. Wang F,
   2. Lyu H,
   3. Zhao M, et al

   . Assessment of cochlea endolymphatic hydrops using 3-D FLAIR and 3-D Real IR sequence in guinea pigs via 3T MRI after intratympanic gadolinium: a histopathological comparison. Otol Neurotol 2017;38:585–90 doi:10.1097/MAO.0000000000001331 pmid:28072657

   CrossRefPubMed
10. 10.↵
    1. Naganawa S,
    2. Sone M,
    3. Yamazaki M, et al

    . Visualization of endolymphatic hydrops after intratympanic injection of Gd-DTPA: comparison of 2D and 3D real inversion recovery imaging. Magn Reson Med Sci 2011;10:101–06 doi:10.2463/mrms.10.101 pmid:21720112

    CrossRefPubMed
11. 11.↵
    1. Baráth K,
    2. Schuknecht B,
    3. Naldi AM, et al

    . Detection and grading of endolymphatic hydrops in Meniere disease using MR imaging. AJNR Am J Neuroradiol 2014;35:1387–92 doi:10.3174/ajnr.A3856 pmid:24524921

    Abstract/FREE Full Text
12. 12.↵
    1. van Steekelenburg JM,
    2. van Weijnen A,
    3. de Pont LM, et al

    . Value of endolymphatic hydrops and perilymph signal intensity in suspected Meniere disease. AJNR Am J Neuroradiol 2020;41:529–34 doi:10.3174/ajnr.A6410 pmid:32029469

    Abstract/FREE Full Text
13. 13.↵
    1. Blasche MR,
    2. Riffel P,
    3. Lichy M

    . TimTX TrueShape and syngo ZOOMit technical and practical aspects. Magnetom Flash 2012;1:74–84
14. 14.↵
    1. Naganawa SK,
    2. Fukatsu H,
    3. Ishigaki T, et al

    . High-speed imaging at 3 Tesla: a technical and clinical review with an emphasis on whole-brain 3D imaging. Magn Reson Med Sci 2004;3:177–87 doi:10.2463/mrms.3.177 pmid:16093636

    CrossRefPubMed
15. 15.↵
    1. Riffel PM,
    2. Michaely HJ

    . Improved echo planar diffusion-weighted imaging of the head and neck using syngo ZOOMit. Magnetom Flash 2013;2:68–71
16. 16.↵
    1. Riffel P,
    2. Michaely HJ,
    3. Morelli JN, et al

    . Zoomed EPI-DWI of the pancreas using two-dimensional spatially-selective radiofrequency excitation pulses. PLoS One 2014;9:e89468 doi:10.1371/journal.pone.0089468 pmid:24594702

    CrossRefPubMed
17. 17.↵
    1. Schulze M,
    2. Seeger A,
    3. Reimann K, et al

    . Parallel-transmit-accelerated 2D selective RF excitation MR of the temporal bone: enhanced resolution of labyrinthine and IAC structures. Otol Neurotol 2016;37:408–14 doi:10.1097/MAO.0000000000000986 pmid:26927760

    CrossRefPubMed
18. 18.↵
    1. Schulze M,
    2. Reimann K,
    3. Seeger A, et al

    . Improvement in imaging common temporal bone pathologies at 3 T MRI: small structures benefit from a small field of view. Clin Radiol 2017;72:e261e1–67e21 doi:10.1016/j.crad.2016.11.019 pmid:28034444

    CrossRefPubMed
19. 19.↵
    1. Xie J,
    2. Zhang W,
    3. Zhu J, et al

    . Comparison of inner ear MRI enhancement in patients with Meniere’s disease after intravenous injection of gadobutrol, gadoterate meglumine, or gadodiamide. Eur J Radiol 2021;139:109682 doi:10.1016/j.ejrad.2021.109682 pmid:33813284

    CrossRefPubMed
20. 20.↵
    1. Eliezer M,
    2. Poillon G,
    3. Gillibert A, et al

    . Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere’s disease. Diagn Interv Imaging 2018;99:271–77 doi:10.1016/j.diii.2018.01.002 pmid:29398574

    CrossRefPubMed
21. 21.↵
    1. Li J,
    2. Sun L,
    3. Wang L, et al

    . Contrast-enhanced three-dimensional fluid-attenuated inversion recovery imaging with an optimal scan interval and angulation to visualize endolymphatic hydrops. Iran J Radiol 2022;19:e122424 doi:10.5812/iranjradiol-122424

    CrossRef
22. 22.↵
    1. Ohashi T,
    2. Naganawa S,
    3. Takeuchi A, et al

    . Quantification of endolymphatic space volume after intravenous administration of a single dose of gadolinium-based contrast agent: 3D-real inversion recovery versus HYDROPS-Mi2. Magn Reson Med Sci 2020;19:119–24 doi:10.2463/mrms.mp.2019-0013 pmid:31061269

    CrossRefPubMed
23. 23.↵
    1. Naganawa S,
    2. Kawai H,
    3. Sone M, et al

    . Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010;9:73–80 doi:10.2463/mrms.9.73 pmid:20585197

    CrossRefPubMed
24. 24.↵
    1. Bernaerts A,
    2. Vanspauwen R,
    3. Blaivie C, et al

    . The value of four stage vestibular hydrops grading and asymmetric perilymphatic enhancement in the diagnosis of Meniere’s disease on MRI. Neuroradiology 2019;61:421–29 doi:10.1007/s00234-019-02155-7 pmid:30719545

    CrossRefPubMed
25. 25.↵
    1. Nakashima T,
    2. Naganawa S,
    3. Pyykko I, et al

    . Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009:5–8 doi:10.1080/00016480902729827 pmid:19221900

    CrossRefPubMed
26. 26.↵
    1. Seeger A,
    2. Schulze M,
    3. Schuettauf F, et al

    . Advanced diffusion-weighted imaging in patients with optic neuritis deficit: value of reduced field of view DWI and readout-segmented DWI. Neuroradiol J 2018;31:126–32 doi:10.1177/1971400918757711 pmid:29417865

    CrossRefPubMed
27. 27.↵
    1. Morimoto K,
    2. Yoshida T,
    3. Sugiura S, et al

    . Endolymphatic hydrops in patients with unilateral and bilateral Meniere’s disease. Acta Otolaryngol 2017;137:23–28 doi:10.1080/00016489.2016.1217042 pmid:27564645

    CrossRefPubMed
28. 28.↵
    1. Shi S,
    2. Guo P,
    3. Wang W

    . Magnetic resonance imaging of Meniere’s disease after intravenous administration of gadolinium. Ann Otol Rhinol Laryngol 2018;127:777–82 doi:10.1177/0003489418794699 pmid:30156867

    CrossRefPubMed
29. 29.↵
    1. Chen W,
    2. Geng Y,
    3. Niu Y, et al

    . Inner ear MRI enhancement based on three dimensional-real IR sequence in patients with Meniere’s disease after intravenous gadolinium injection: comparison of different doses used and exploration of an appropriate dose. Clin Otolaryngol 2022;47:717–23 doi:10.1111/coa.13912 pmid:35034431

    CrossRefPubMed
30. 30.↵
    1. Tagaya M,
    2. Yamazaki M,
    3. Teranishi M, et al

    . Endolymphatic hydrops and blood-labyrinth barrier in Meniere’s disease. Acta Otolaryngol 2011;131:474–79 doi:10.3109/00016489.2010.534114 pmid:21198346

    CrossRefPubMed
31. 31.↵
    1. Yamazaki M,
    2. Naganawa S,
    3. Tagaya M, et al

    . Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection. AJNR Am J Neuroradiol 2012;33:773–78 doi:10.3174/ajnr.A2821 pmid:22173762

    Abstract/FREE Full Text
32. 32.↵
    1. Suzuki H,
    2. Teranishi M,
    3. Sone M, et al

    . Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents. Acta Otolaryngol 2011;131:1025–31 doi:10.3109/00016489.2011.598552 pmid:21732744

    CrossRefPubMed
33. 33.↵
    1. Zhang W,
    2. Xie J,
    3. Hui L, et al

    . The correlation between endolymphatic hydrops and blood-labyrinth barrier permeability of Meniere disease. Ann Otol Rhinol Laryngol 2021;130:578–84 doi:10.1177/0003489420964823 pmid:33047609

    CrossRefPubMed